Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.21 INR -1.36%
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Bharat Immunologicals and Biologicals Corporation Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bharat Immunologicals and Biologicals Corporation Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Operating Expenses
-â‚ą61.2m
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
12%
Transgene Biotek Ltd
BSE:526139
Operating Expenses
-â‚ą11.5m
CAGR 3-Years
52%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Operating Expenses
-â‚ą325.8m
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-12%
Hester Biosciences Ltd
NSE:HESTERBIO
Operating Expenses
-â‚ą1.8B
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Operating Expenses
-â‚ą84.7B
CAGR 3-Years
-28%
CAGR 5-Years
-23%
CAGR 10-Years
-21%
Panacea Biotec Ltd
NSE:PANACEABIO
Operating Expenses
-â‚ą4B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Bharat Immunologicals and Biologicals Corporation Ltd
Glance View

Market Cap
1B INR
Industry
Biotechnology

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BIBCL Intrinsic Value
5.26 INR
Overvaluation 77%
Intrinsic Value
Price

See Also

What is Bharat Immunologicals and Biologicals Corporation Ltd's Operating Expenses?
Operating Expenses
-61.2m INR

Based on the financial report for Sep 30, 2023, Bharat Immunologicals and Biologicals Corporation Ltd's Operating Expenses amounts to -61.2m INR.

What is Bharat Immunologicals and Biologicals Corporation Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
12%

Over the last year, the Operating Expenses growth was 34%. The average annual Operating Expenses growth rates for Bharat Immunologicals and Biologicals Corporation Ltd have been 18% over the past three years , 9% over the past five years , and 12% over the past ten years .

Back to Top